Pharmacy

Exermet P 515 Actosplus Met

Home » Prescription Drugs 7 » Exermet P 515 Actosplus Met

Treating type 2 diabetes. It is used along with diet and exercise. It may be used alone or with other antidiabetic medicines.Metformin/Pioglitazone is a biguanide and thiazolidinedione antidiabetic combination. It works by decreasing the amount of sugar the liver produces and the intestines absorb. It also helps to make your body more sensitive to the insulin that you naturally produce.Adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes who are already treated with pioglitazone plus metformin or whose diabetes is not adequately controlled with metformin alone or for those patients who initially responded to pioglitazone alone and require additional glycemic control.

Buy Exermet P 515 Actosplus Met and other Prescription Drugs 7 products online at Medstore.

Buy Online at Medstore - Click Here!

About Exermet P 515 Actosplus Met:

Product Type: Prescription Drugs 7

Exermet P (515) ( Actosplus Met Generic Pioglitazone & Metformin )

Exermet P (515 Actosplus Met Generic Pioglitazone & Metformin)

515 Actosplus Met Generic Pioglitazone & Metformin

15mg/500mg 180 Tablets 90 Tabs 515 Actosplus Met Generic Pioglitazone & Metformin Exermet P

View more Prescription Drugs 7

Previous Product  Next Product

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.